Full Schedule

07:00 – 08:00 CST

Breakfast Session: Ask an expert

Location: Michigan A/B

Primary Presenter: – CDC

07:00 – 08:00 CST

Breakfast Session: Comprehensive Care for Women with STIs and Vaginitis: The Role of Molecular Diagnostics in Co-Testing to Avoid Missed Diagnoses

Location: Chicago 9

Invited Speaker: – Division of Infectious Diseases, University of Alabama at Birmingham

07:00 – 08:00 CST

Breakfast Session: Mycoplasma genitalium: Understanding prevalence and clinical management of infection in high-risk populations

Location: Chicago 10

07:00 – 18:00 CST

Design-a-thon: Community Group

Location: Arkansas

07:00 – 18:00 CST

Design-a-thon: Early Career Research Group

Location: Mississippi

07:00 – 18:00 CST

Design-a-thon: Silver Group

Location: Ohio

07:00 – 18:00 CST

Design-a-thon: Traveller Group

Location: Colorado

08:30 – 09:30 CST

Plenary 1: Sexual Health: Trust and Rights

Location: Sheraton Ballroom

Moderator: – Tulane University School of Public Health and Tropical Medicine

Moderator: – NHS Greater Glasgow and Clyde

Invited Talk

08:30 – 09:00 CST

PL1.1 - How can we regain trust in science?

Location: Sheraton Ballroom

Invited Speaker: – Department of Population and Public Health Sciences, University of Southern California

Invited Talk

09:00 – 09:30 CST

PL1.2 - Gender, health inequality and reproductive rights

Location: Sheraton Ballroom

Invited Speaker: – UCL

Invited Talk

10:00 – 11:30 CST

Vaginal Conditions

Location: Chicago 8

Moderator: – Julius Center of Health Sciences and Primary Care, University Medical Center Utrecht

Moderator: – Washington University in St. Louis, School of Medicine

10:00 – 10:15 CST

O1.1 - Bacterial Vaginosis and Spontaneous Clearance of Urogenital Chlamydia trachomatis in the Longitudinal Study of Vaginal Flora

Location: Chicago 8

Primary Presenter: – University of Maryland School of Medicine

Epidemiology & Monitoring

10:15 – 10:30 CST

O1.2 - The contribution of the vaginal microbiota to treatment failure following first-line antibiotics for bacterial vaginosis

Location: Chicago 8

Primary Presenter: – Monash University and Melbourne Sexual Health Centre

Basic & Translational Science

10:30 – 10:45 CST

O1.3 - Increasing rates of non-albicans Candida species and fluconazole resistant Candida albicans in women with recurrent vulvovaginal candidiasis in a UK region

Location: Chicago 8

Primary Presenter: – The Leeds Teaching Hospitals NHS Trust

Clinical Science

10:45 – 11:00 CST

O1.4 - Sexual transmission of urogenital bacteria in heterosexual partners: whole metagenome sequencing evidence from a sexual network study

Location: Chicago 8

Primary Presenter: – Institute for Genome Sciences, University of Maryland School of Medicine

Basic & Translational Science

11:00 – 11:15 CST

O1.5 - Secreted Proteases from Bacterial Vaginosis-Associated Bacteria Target Human MMP-8 and Modulate Endocervical Barrier Function

Location: Chicago 8

Primary Presenter: – University of Calgary, Canada

Basic & Translational Science

11:15 – 11:30 CST

O1.6 - Spontaneous resolution and treatment outcomes in men with Trichomonas vaginalis infection

Location: Chicago 8

Primary Presenter: – Division of Infectious Diseases, University of Alabama at Birmingham

Clinical Science

10:00 – 11:30 CST

Reaching the vulnerable

Location: Chicago 9

Moderator: – Ohio State University

Moderator:

10:00 – 10:15 CST

O2.1 - Calculating the value of behavioural science and community engagement in promoting vaccination of MSM: a transmission-dynamic health-economic analysis of 4CMenB (Bexsero) vs gonorrhoea as an example

Location: Chicago 9

Primary Presenter: – Imperial College London

Co-Author: – MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London

Policy & Community Engagement

10:15 – 10:30 CST

O2.2 - Relationships and risk: A mixed-methods study of perceptions and management of STI/HIV risk among heterosexual-identifying men who have sex with both men and women

Location: Chicago 9

Primary Presenter: – University of Victoria

Behavioral & Social Science

10:30 – 10:45 CST

O2.3 - “It’s not safe for me and what would it achieve?” Acceptability of patient referral partner notification for sexually transmitted infections to adolescents and young people in Zimbabwe

Location: Chicago 9

Primary Presenter: – London School of Hygiene & Tropical Medicine

Implementation Science

10:45 – 11:00 CST

O2.4 - Preparedness of pregnant women to wait for same-day results of sexually transmitted infections

Location: Chicago 9

Primary Presenter: – 1) Institute of Social and Preventive Medicine, University of Bern, Switzerland 2) Research Unit, Foundation for Professional Development, South Africa

Implementation Science

11:00 – 11:15 CST

O2.5 - Mixed methods analysis of network structures, support exchanged, and communication patterns within the social networks of transgender women in Lima, Peru

Location: Chicago 10

Primary Presenter: – Department of Medicine, David Geffen School of Medicine at UCLA, Division of Infectious Diseases, Los Angeles, CA, USA

Co-Author: – David Geffen School of Medicine at UCLA, Los Angeles, CA

Behavioral & Social Science

11:15 – 11:30 CST

O2.6 - Community-based integrated HIV and sexual and reproductive health services: why did we miss young men and what is it going to take to reach them?

Location: Chicago 9

Primary Presenter: – Biomedical Research and Training Institute

Implementation Science

10:00 – 11:30 CST

Syphilis: Epidemiology and Clinical

Location: Chicago 10

Moderator: – World Health Organization

Moderator: – Johns Hopkins University School of Medicine - Division of Infectious DIseases

10:00 – 10:15 CST

O3.1 - Evaluating the clinical features of reported breakthrough cases of congenital syphilis — United States, 2016–2020

Location: Chicago 10

Primary Presenter: – Centers for Disease Control and Prevention

Epidemiology & Monitoring

10:15 – 10:30 CST

O3.2 - Rates of reported primary and secondary syphilis among men who have sex with men compared to men who have sex with women only and women who have sex with men in 37 US states, 2018

Location: Chicago 10

Primary Presenter: – CDC

Epidemiology & Monitoring

10:30 – 10:45 CST

O3.3 - Detection of Treponema pallidum at asymptomatic oral, anal and vaginal sites in men and women reporting contact with syphilis.

Location: Chicago 10

Primary Presenter: – Melbourne Sexual Health Centre, The Alfred Health , Melbourne, Victoria

Clinical Science

10:45 – 11:00 CST

O3.4 - Evolutionary insights into syphilis epidemiology - applying Treponema pallidum genomics in high- and low-income settings

Location: Chicago 10

Primary Presenter: – Wellcome Sanger Institute

Basic & Translational Science

11:00 – 11:15 CST

O3.5 - Temporal Trends in HIV Status by Race/Ethnicity Among Reported Primary and Secondary Syphilis Cases Among Gay, Bisexual, and Other Men who have sex with Men — United States, 2011–2020

Location: Chicago 10

Primary Presenter: – Centers for Disease Control and Prevention

Epidemiology & Monitoring

11:15 – 11:30 CST

O3.6 - Rapid Plasma Reagin (RPR) sero-reversion after treatment and its association with Prior Treponema Pallidum infection: analysis from the PICASSO cohort among people with early syphilis in Peru

Location: Chicago 10

Primary Presenter: – Centro de Investigación Interdisciplinaria en Sexualidad, SIDA y Sociedad, Universidad Peruana Cayetano Heredia

Clinical Science

10:00 – 11:30 CST

Innovations in STI Care

Location: Sheraton Ballroom

Moderator: – South African Medical Research Council

Moderator: – London School of Hygiene & Tropical Medicine

Invited Talk

10:05 – 10:25 CST

SP1.1 - How to maximise potential of point-of-care tests & decentralised testing

Location: Sheraton Ballroom

Invited Speaker: – World Health Organization

Invited Talk

10:25 – 10:45 CST

SP1.2 - How much could automated health care replace clinicians?

Location: Sheraton Ballroom

Invited Speaker: – School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK

Invited Talk

10:45 – 11:05 CST

SP1.3 - Social innovation and STI care

Location: Sheraton Ballroom

Invited Speaker: – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK

Invited Talk

10:00 – 11:30 CST

Tackling stigma, strengthening communities

Location: Chicago 6

Moderator: – University of Brasília / Oswaldo Cruz Foundation (Instituto Leonidas & Maria Deane)

Moderator: – Johns Hopkins School of Medicine

Invited Talk

10:05 – 10:25 CST

SY1.1 - STIs: the risk of stigmatising stigma

Location: Chicago 6

Invited Speaker: – AHF GLOBAL PUBLIC HEALTH INSTITUTE

Invited Talk

10:25 – 10:45 CST

SY1.2 - Decriminalization of same-sex relations and social attitudes

Location: Chicago 6

Invited Speaker: – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

Invited Talk

10:45 – 11:05 CST

SY1.3 - The Longest Mile: Stigma’s impact on sexual health for women in the Southern US

Location: Chicago 6

Invited Speaker: – University of Alabama at Birmingham, School of Medicine, Division of Infectious Diseases

Invited Talk

10:00 – 11:30 CST

Worldwide strategies against antimicrobial resistance

Location: Chicago 7

Moderator: – Institut Pasteur de Madagascar

Moderator: – Örebro University

Invited Talk

10:05 – 10:10 CST

SY2.1 - Setting the scene: STI treatment options are running out due to AMR

Location: Chicago 7

Invited Speaker: – Örebro University

Invited Talk

10:10 – 10:30 CST

SY2.2 - Molecular resistance prediction and resistance-guided STI therapy - when and how to use

Location: Chicago 7

Invited Speaker: – Monash University and Melbourne Sexual Health Centre

Invited Talk

10:30 – 10:50 CST

SY2.3 - Future treatments for STIs

Location: Chicago 7

Invited Speaker: – University of Washington

Invited Talk

10:50 – 11:05 CST

SY2.4 - Doxycycline PrEP and PEP - impact on microbiome and antimicrobial resistance

Location: Chicago 7

Invited Speaker: – The University of Melbourne

Invited Talk

11:05 – 11:25 CST

SY2.5 - Optimising STI treatment using pharmacodynamics

Location: Chicago 7

Invited Speaker: – Örebro University

Invited Talk

11:30 – 13:00 CST

Advocacy Zone

Location: Exhibit Hall

11:30 – 13:00 CST

Lunch Session: The importance of meeting underserved women where they are (Lunch is only available to session attendees)

Location: Sheraton Ballroom

13:00 – 14:00 CST

Plenary 2: Sexual Health and Sexual Pleasure

Location: Sheraton Ballroom

Moderator:

Invited Talk

13:00 – 13:30 CST

PL2.1 - Putting pleasure back into sexual health - 1

Location: Sheraton Ballroom

Invited Speaker: – CUNY School of Medicine

Invited Talk

13:30 – 14:00 CST

PL2.2 - Putting pleasure back into sexual health - 2

Location: Sheraton Ballroom

Invited Speaker: – AUBMC

Invited Talk

14:30 – 16:00 CST

Optimizing urethritis treatment – M. genitalium and pathogens of idiopathic urethritis

Location: Chicago 8

Moderator: – Indiana University School of Medicine

Moderator: – Statens Serum Institut

14:30 – 14:45 CST

O4.1 - Exploring current etiologies of urethritis: associations of urethral microorganisms and urethritis among men attending 6 STD clinics in the US, 2017-2018

Location: Chicago 8

Primary Presenter: – Division of STD Prevention, Centers for Disease Control and Prevention

Epidemiology & Monitoring

14:45 – 15:00 CST

O4.2 - gyrA mutations in Mycoplasma genitalium contribute to moxifloxacin failure – a new target for resistance-guided therapy

Location: Chicago 8

Primary Presenter: – University of Melbourne

Basic & Translational Science

15:00 – 15:15 CST

O4.3 - MgSeq: Enabling M. genitalium identification and antimicrobial resistance detection in genital and extra-genital samples from female sex workers in Ecuador using multiplex PCR and nanopore sequencing

Location: Chicago 8

Primary Presenter: – St George's, University of London

Basic & Translational Science

15:15 – 15:30 CST

O4.4 - Mycoplasma genitalium Surveillance Data from 2020-2022: Results from the Mycoplasma genitalium in the US (MyGeniUS) Project

Location: Chicago 8

Primary Presenter: – University of Washington

Epidemiology & Monitoring

15:30 – 15:45 CST

O4.5 - Efficacy of minocycline for the treatment of Mycoplasma genitalium

Location: Chicago 8

Primary Presenter: – Monash University and Melbourne Sexual Health Centre

Clinical Science

15:45 – 16:00 CST

O4.6 - Idiopathic nongonococcal urethritis may be due to emerging and spontaneously cleared pathogens

Location: Chicago 8

Primary Presenter: – Indiana University Schol of Medicine

Basic & Translational Science

14:30 – 16:00 CST

HIV PrEP, Viral STIs

Location: Chicago 9

Moderator:

Moderator: – University of Illinois at Chicago (UIC)

14:30 – 14:45 CST

O5.1 - PrEP Method Preferences and Anticipated Stigma Among Female, Male, and Transgender Sex Workers in India

Location: Chicago 9

Primary Presenter: – Department of Population and Public Health Sciences, University of Southern California

Behavioral & Social Science

14:45 – 15:00 CST

O5.2 - THE ACCEPTABILITY OF PHARMACY-DELIVERED PREP IN KENYA: PROVIDER AND CLIENT PERCEPTIONS

Location: Chicago 9

Primary Presenter: – Kenya Medical Research Institute

Implementation Science

15:00 – 15:15 CST

O5.3 - Concordance between self-reported PrEP use using a diary app and intracellular tenofovir diphosphate in the Amsterdam PrEP demonstration project

Location: Chicago 9

Primary Presenter: – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands

Primary Presenter: – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands; Amsterdam UMC location University of Amsterdam, Department of Infectious Diseases, Amsterdam Institute for Infection & Immunity (AII), Amsterdam, the Netherlands.

Epidemiology & Monitoring

15:15 – 15:30 CST

O5.4 - Age patterns of HSV-2 incidence and prevalence in two communities in Rakai, Uganda: a catalytic incidence model applied to population-based seroprevalence data

Location: Chicago 9

Primary Presenter: – Imperial College London

Epidemiology & Monitoring

15:30 – 15:45 CST

O5.5 - Pritelivir for the treatment of resistant HSV infections in immunocompromised patients: update on an ongoing Phase 3 trial and Early Access Program

Location: Chicago 9

Primary Presenter: – AiCuris Anti-Infective Cures AG

Clinical Science

15:45 – 16:00 CST

O5.6 - Knowledge and acceptability of Human Papillomavirus vaccination for young adult women in rural Mysore District, India: a qualitative study

Location: Chicago 9

Primary Presenter: – David Geffen School of Medicine at UCLA

Behavioral & Social Science

14:30 – 16:00 CST

Biomedical prevention for STIs and HIV

Location: Chicago 10

Moderator:

Moderator: – University of Oxford

14:30 – 14:45 CST

O6.1 - High uptake of Doxycycline for STI prevention (doxy-PEP) among individuals using HIV PrEP at a municipal sexual health clinic in San Francisco, California

Location: Chicago 10

Primary Presenter: – San Francisco City Clinic, San Francisco Department of Public Health

Implementation Science

14:45 – 15:00 CST

O6.2 - Syphilis testing, incidence, and reinfection among gay and bisexual men with and without HIV in Australia over a decade spanning HIV PrEP implementation

Location: Chicago 10

Primary Presenter: – Burnet Institute

Epidemiology & Monitoring

15:00 – 15:15 CST

O6.3 - Self-reported adherence to event-driven doxycycline postexposure prophylaxis for sexually transmitted infection prevention among cisgender women

Location: Chicago 10

Primary Presenter: – Hennepin Healthcare Research Institute and University of Minnesota

Behavioral & Social Science

15:15 – 15:30 CST

O6.4 - A genomic perspective on the near-term impact of doxycycline post-exposure prophylaxis on Neisseria gonorrhoeae antimicrobial resistance

Location: Chicago 10

Primary Presenter: – Harvard T.H. Chan School of Public Health

Epidemiology & Monitoring

15:30 – 15:45 CST

O6.5 - Discontinuation of Pre-Exposure Prophylaxis and associated factors among Female Commercial Sex Workers attending the most at-risk population clinic, Mulago Hospital, Uganda

Location: Chicago 10

Primary Presenter: – Makerere University School of Public Health

Behavioral & Social Science

15:45 – 16:00 CST

O6.6 - PrEP outcomes and sexual health in China during COVID-19 lockdowns

Location: Chicago 10

Primary Presenter: – Tokyo College, University of Tokyo; University of North Carolina Project China

Behavioral & Social Science

14:30 – 16:00 CST

Late Breaker 1: LGV, chlamydia and mpox

Location: Michigan A/B

Moderator: – University of Bern

Moderator: – Institute for Glycomics, Griffith University

14:30 – 14:45 CST

LB1.1 - Prevalence and epidemiology of Lymphogranuloma venereum in France, 2020-2022

Location: Michigan A+B

Primary Presenter: – Bordeaux University Hospital

Epidemiology & Monitoring

14:45 – 15:00 CST

LB1.2 - Genetic diversity of Chlamydia trachomatis infection among patients presenting with genital lesions in Malawi

Location: Michigan A+B

Primary Presenter: – Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

Epidemiology & Monitoring

15:00 – 15:15 CST

LB1.3 - Evaluating immunological responses of mRNA-based Chlamydia vaccines

Location: Michigan A+B

Primary Presenter: – Lawrence Livermore National Laboratory

Basic & Translational Science

15:15 – 15:30 CST

LB1.4 - Mpox resurgence in 2023 in Toronto, Canada – surveillance and vaccine approaches

Location: Michigan A+B

Primary Presenter: – Toronto Public Health

Co-Author: – Toronto Public Health

Epidemiology & Monitoring

15:30 – 15:45 CST

LB1.5 - Modelling the impact of vaccination and sexual behavior adaptation on reported cases of mpox in Washington D.C.

Location: Michigan A+B

Primary Presenter: – Centers for Disease Control and Prevention

Epidemiology & Monitoring

15:45 – 16:00 CST

LB1.6 - Modeling potential mpox resurgence among gay, bisexual, and other men who have sex with men in Washington, DC.

Location: Michigan A+B

Primary Presenter: – Centers for Disease Control & Prevention

Epidemiology & Monitoring

14:30 – 16:00 CST

STI guidelines

Location: Sheraton Ballroom

Moderator:

Moderator: – Centers for Disease Control/DSTDP

Invited Talk

14:35 – 14:55 CST

SP2.1 - Why are there differences in our guidelines?

Location: Sheraton Ballroom

Invited Speaker: – Emory University

Invited Talk

14:55 – 15:15 CST

SP2.2 - Addressing trans and non-binary health in guidelines

Location: Sheraton Ballroom

Invited Speaker: – Callen-Lorde Community Health Center

Invited Talk

15:15 – 15:35 CST

SP2.3 - Living guidelines - what does good look like?

Location: Sheraton Ballroom

Invited Speaker: – Bucks Healthcare NHS Trust

Invited Talk

14:30 – 16:00 CST

Vaccines for STI prevention: development, acceptance and equity

Location: Chicago 6

Moderator: – University of Victoria, Canada & University of Washington, USA

Moderator: – University of Washington & Fred Hutchinson Cancer Center

Invited Talk

14:35 – 14:55 CST

SY3.1 - State of syphilis vaccine development

Location: Chicago 6

Invited Speaker: – University of Washington

Invited Talk

14:55 – 15:15 CST

SY3.2 - State of vaccine development for Neisseria gonorrhoeae

Location: Chicago 6

Invited Speaker: – University of Massachusetts Chan Medical School

Invited Talk

15:15 – 15:35 CST

SY3.3 - State of chlamydia vaccine development

Location: Chicago 6

Invited Speaker: – Centre for Vaccine Research, Statens Serum Institut

Invited Talk

15:35 – 15:55 CST

SY3.4 - STI Vaccine Acceptance and Equity

Location: Chicago 6

Invited Speaker: – AVAC

Invited Talk

14:30 – 16:00 CST

Queer Theory & Intersectionality in STI Prevention and Care

Location: Chicago 7

Moderator: – Queen's University

Moderator: – University of Chicago Medical Center

Invited Talk

14:35 – 14:55 CST

SY4.1 - Centering Sex Positivity in STI & HIV prevention

Location: Chicago 7

Invited Speaker: – RuthMorganThomas

Invited Talk

14:55 – 15:15 CST

SY4.2 - Community-Led Responses: Vital for Effective STI Interventions, Policy and Impact

Location: Chicago 7

Invited Speaker: – International Treatment Preparedness Coalition (ITPC)

Invited Talk

15:15 – 15:35 CST

SY4.3 - Chemsex and Sexualised Drug Use

Location: Chicago 7

Invited Speaker: – University of California San Francisco

Invited Talk

15:35 – 15:55 CST

SY4.4 - Trans and non-binary sexual health

Location: Chicago 7

Invited Speaker: – Division of Infectious Diseases, University of Alabama at Birmingham

Invited Talk

16:00 – 17:00 CST

Invite Only: NIH Magi meeting

Location: Huron

16:00 – 18:00 CST

Advocacy Zone

Location: Exhibit Hall

16:00 – 18:00 CST

Invite Only: CDC STIIR Consortium

Location: Mayfair

16:00 – 18:00 CST

Poster Session

Location: Riverwalk A/B

16:30 – 18:00 CST

Atlas of Queer Anatomy Workshop - Sign up Requested

Location: Erie

Invited Speaker: – Public Health Service Amsterdam and Amsterdam University Medical Centre